Bioinformatics Institute, A*STAR, 30 Biopolis Street, #07-01 Matrix, Singapore, 138671, Singapore.
Biotransformation Innovation Platform, A*STAR, 61 Biopolis Drive, Proteos Level 4, Singapore, 138673, Singapore.
Microb Cell Fact. 2020 Mar 19;19(1):71. doi: 10.1186/s12934-020-01328-x.
Notonesomycin A is a 32-membered bioactive glycosylated macrolactone known to be produced by Streptomyces aminophilus subsp. notonesogenes 647-AV1 and S. aminophilus DSM 40186. In a high throughput antifungal screening campaign, we identified an alternative notonesomycin A producing strain, Streptomyces sp. A793, and its biosynthetic gene cluster. From this strain, we further characterized a new more potent antifungal non-sulfated analogue, named notonesomycin B. Through CRISPR-Cas9 engineering of the biosynthetic gene cluster, we were able to increase the production yield of notonesomycin B by up to 18-fold as well as generate a strain that exclusively produces this analogue.
无冬霉素 A 是一种 32 元生物活性糖基大环内酯,已知由链霉菌属氨基醇亚种。notonesogenes 647-AV1 和 S. 氨基醇 DSM 40186 产生。在高通量抗真菌筛选活动中,我们确定了一种替代无冬霉素 A 产生菌,链霉菌属 A793 及其生物合成基因簇。从该菌株中,我们进一步鉴定了一种新的、更有效的非硫酸化类似物,命名为无冬霉素 B。通过生物合成基因簇的 CRISPR-Cas9 工程,我们能够将无冬霉素 B 的产量提高至 18 倍,并生成一种专门产生该类似物的菌株。